Changes in nitric oxide levels and antioxidant enzyme activities may have a role in the pathophysiological mechanisms involved in autism
- 1 May 2003
- journal article
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 331 (1-2) , 111-117
- https://doi.org/10.1016/s0009-8981(03)00119-0
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Plasma malondialdehyde and nitric oxide levels in age related macular degenerationBritish Journal of Ophthalmology, 2001
- Micronutrient accumulation and depletion in schizophrenia, epilepsy, autism and Parkinson’s disease?Medical Hypotheses, 2001
- Red blood cell fatty acid compositions in a patient with autistic spectrum disorder: a characteristic abnormality in neurodevelopmental disorders?Prostaglandins, Leukotrienes & Essential Fatty Acids, 2000
- Fatty acid metabolism in neurodevelopmental disorder: a new perspective on associations between attention-deficit/hyperactivity disorder, dyslexia, dyspraxia and the autistic spectrumProstaglandins, Leukotrienes & Essential Fatty Acids, 2000
- Autism: a mitochondrial disorder?Medical Hypotheses, 1998
- Peroxisomal disturbances in children with epilepsy, hypoxia and autism: Patricia C Kane, Mark S Schauss Body Bio Centre, Millville, New Jersey USAProstaglandins, Leukotrienes & Essential Fatty Acids, 1997
- Endotoxin triggers the expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in the rat aorta in vivoFEBS Letters, 1995
- The Emerging Multifaceted Roles of Nitric OxideAnnals of Surgery, 1995
- A novel neuronal messenger molecule in brain: The free radical, nitric oxideAnnals of Neurology, 1992
- Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydesFree Radical Biology & Medicine, 1991